
- <Centre d'Information et de documentation du CRA Rhône-Alpes
- CRA
- Informations pratiques
-
Adresse
Centre d'information et de documentation
Horaires
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexLundi au Vendredi
Contact
9h00-12h00 13h30-16h00Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Adresse
Détail de l'auteur
Auteur I. IBARRA-GONZÁLEZ |
Documents disponibles écrits par cet auteur (1)



Brief Report: Delayed Diagnosis of Treatable Inborn Errors of Metabolism in Children with Autism and Other Neurodevelopmental Disorders / M. E. MÁRQUEZ-CARAVEO in Journal of Autism and Developmental Disorders, 51-6 (June 2021)
![]()
[article]
Titre : Brief Report: Delayed Diagnosis of Treatable Inborn Errors of Metabolism in Children with Autism and Other Neurodevelopmental Disorders Type de document : Texte imprimé et/ou numérique Auteurs : M. E. MÁRQUEZ-CARAVEO, Auteur ; I. IBARRA-GONZÁLEZ, Auteur ; R. RODRÍGUEZ-VALENTÍN, Auteur ; Miguel Ángel RAMÍREZ-GARCÍA, Auteur ; V. PÉREZ-BARRÓN, Auteur ; E. LAZCANO-PONCE, Auteur ; M. VELA-AMIEVA, Auteur Article en page(s) : p.2124-2131 Langues : Anglais (eng) Mots-clés : Adolescent Autism Spectrum Disorder/complications Child Delayed Diagnosis/statistics & numerical data Female Humans Male Metabolism, Inborn Errors/diagnosis/epidemiology/psychology Mexico/epidemiology Neurodevelopmental Disorders/complications Tandem Mass Spectrometry/methods Autism spectrum disorders Inborn errors of metabolism Intellectual disabilities Metabolic screening Neurodevelopmental disorders Index. décimale : PER Périodiques Résumé : The objective of our study was to evaluate the frequency of treatable inborn errors of metabolism (IEM) in a clinical sample of Mexican children and adolescents with neurodevelopmental disorders (NDD). Amino acids and acylcarnitines in blood samples of 51 unrelated children and adolescents were analyzed by tandem mass spectrometry to detect treatable IEM of small molecules. One patient with isovaleric acidemia and autism spectrum disorder (ASD) and another with beta-ketothiolase deficiency and ASD/intellectual disability/attention-deficit/hyperactivity disorder (ADHD) were diagnosed, indicating an IEM frequency of 3.9% (1:26 subjects). The high frequency of treatable IEM indicates the need to perform a minimum metabolic screening as part of the diagnostic approach for patient with NDD, particularly when newborn screening programs are limited to a few disorders. En ligne : http://dx.doi.org/10.1007/s10803-020-04682-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=452
in Journal of Autism and Developmental Disorders > 51-6 (June 2021) . - p.2124-2131[article] Brief Report: Delayed Diagnosis of Treatable Inborn Errors of Metabolism in Children with Autism and Other Neurodevelopmental Disorders [Texte imprimé et/ou numérique] / M. E. MÁRQUEZ-CARAVEO, Auteur ; I. IBARRA-GONZÁLEZ, Auteur ; R. RODRÍGUEZ-VALENTÍN, Auteur ; Miguel Ángel RAMÍREZ-GARCÍA, Auteur ; V. PÉREZ-BARRÓN, Auteur ; E. LAZCANO-PONCE, Auteur ; M. VELA-AMIEVA, Auteur . - p.2124-2131.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 51-6 (June 2021) . - p.2124-2131
Mots-clés : Adolescent Autism Spectrum Disorder/complications Child Delayed Diagnosis/statistics & numerical data Female Humans Male Metabolism, Inborn Errors/diagnosis/epidemiology/psychology Mexico/epidemiology Neurodevelopmental Disorders/complications Tandem Mass Spectrometry/methods Autism spectrum disorders Inborn errors of metabolism Intellectual disabilities Metabolic screening Neurodevelopmental disorders Index. décimale : PER Périodiques Résumé : The objective of our study was to evaluate the frequency of treatable inborn errors of metabolism (IEM) in a clinical sample of Mexican children and adolescents with neurodevelopmental disorders (NDD). Amino acids and acylcarnitines in blood samples of 51 unrelated children and adolescents were analyzed by tandem mass spectrometry to detect treatable IEM of small molecules. One patient with isovaleric acidemia and autism spectrum disorder (ASD) and another with beta-ketothiolase deficiency and ASD/intellectual disability/attention-deficit/hyperactivity disorder (ADHD) were diagnosed, indicating an IEM frequency of 3.9% (1:26 subjects). The high frequency of treatable IEM indicates the need to perform a minimum metabolic screening as part of the diagnostic approach for patient with NDD, particularly when newborn screening programs are limited to a few disorders. En ligne : http://dx.doi.org/10.1007/s10803-020-04682-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=452